UCSF Navigation Bar

UCSF Departments of Pathology & Laboratory Medicine Home Page

Lab Manual for UCSF Clinical Laboratories

Lab Manual for SFGH

Internal Resources

Click here for more information about laboratory operations and procedures

If you have additional questions regarding this test, please call: 415-353-1667

Search Our Test Menu

ClonoSeq (Formerly 'ClonoSight')

Please see 'Additional Information'

Item Value
Approval req'd? Yes, for inpatient orders.
Available Stat? No
Test code MOLT (Order in Apex as 'Miscellaneous Outside Lab Test' and specify if sample is to be tested in South San Francisco (aka Sequenta) or Seattle (aka Adaptive Biotechnologies). Please see 'Additional information'
Performed by Sequenta, Inc.
Sendout? Yes
Method PCR/LymphoSIGHT method
Collection Instructions Due to limited sample stability, collect samples Monday-Friday morning only and avoiding holidays.

The lab (Sequenta; South San Francisco) that performed the ClonoSight test was purchased by Adaptive Biotechnologies (Seattle) in May of 2015. The Clonosight test has been renamed 'ClonoSeq' which is the name of a similar test that Adaptive Biotechnologies offered. However, the actual ClonoSight test itself is unchanged.

Patient monitoring should be done using the same assay that their original material was evaluated with. Therefore it is imperative that our sendout department know if the tests should be sent to Adaptive Biotechnologies (Seattle) rather than the lab in South San Francisco.
Container type Lavender top
Amount to Collect
Blood 10 mL
Bone marrow 3 mL
Sample type EDTA anticoagulated blood or bone marrow
Preferred volume
Blood 10 mL
Bone marrow 3 mL
Min. Volume
Blood 10 mL
Bone marrow 3 mL
Processing notes Keep samples at room temperature. Forward to CB at room temperature.
Normal range
Synonyms Molecular Minimal residual disease testing; MRD; ClonoSight
Stability Room temperature 3 days
Turn around times 7-10 days
Additional information The lab (Sequenta; South San Francisco) that performed the ClonoSight test was purchased by Adaptive Biotechnologies (Seattle) in May of 2015. The Clonosight test has been renamed 'ClonoSeq' which is the name of a similar test that Adaptive Biotechnologies offered. However, the actual ClonoSight test itself is unchanged.

Patient monitoring should be done using the same assay that their original material was evaluated with. Therefore it is imperative that our sendout department know if the tests should be sent to Adaptive Biotechnologies (Seattle) rather than the lab in South San Francisco.
Last Updated 6/10/2015 8:41:10 AM
Entry Number 1566
UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center